Targeting the Lysosome for Cancer Therapy. - Wikidata - awgldk - TriplyDB

Targeting the Lysosome for Cancer Therapy.

Targeting the Lysosome for Cancer Therapy.

http://www.wikidata.org/entity/Q47447521

about

Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function

P2860

Q58615792-E4F1AB17-6E9C-4673-9671-56CCFABC2DF6

P2860

Targeting the Lysosome for Cancer Therapy.

http://www.wikidata.org/entity/Q47447521

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Targeting the Lysosome for Cancer Therapy.

@en

Targeting the Lysosome for Cancer Therapy.

@nl

type

label

Targeting the Lysosome for Cancer Therapy.

@en

Targeting the Lysosome for Cancer Therapy.

@nl

prefLabel

Targeting the Lysosome for Cancer Therapy.

@en

Targeting the Lysosome for Cancer Therapy.

@nl

P1433

Q47447521-E4D31EF7-7980-415B-915A-476CCE0B5AD1

P1476

Q47447521-D6561523-FB8D-478E-8F13-00E24EC972E9

P2093

Q47447521-D6656A32-AC59-4FC6-B208-EAF0D241D299

Q47447521-D74A10AB-3533-4E60-8121-54A2E8229A34

P2860

Q47447521-0EB254F3-7BB9-4547-96D0-C3D08474ED6D

Q47447521-2534EC8A-C507-40B3-A099-29E8E77647B9

Q47447521-4E0F4B96-A168-4DC7-8E31-A12389F7B63A

Q47447521-5647C517-5B1A-47D8-B7CD-19F2D7639B5D

Q47447521-66364512-C5F7-4F70-838D-1F8F0155182F

Q47447521-6D62C89D-F3E3-4275-AF7A-3F69EAD0235C

Q47447521-7668CDDF-7764-4BD4-9D2B-7934FB9492B5

Q47447521-C1464027-FC33-442F-B6FF-39157A632769

Q47447521-C563D86B-1BF6-4FE9-A765-F955423EE1FF

Q47447521-C640DE88-0B1B-44F7-82FC-D3E97321A1C8

P304

Q47447521-3CA928CA-B51D-4442-A433-7B9AB42D65B4

P31

Q47447521-38C0EE58-7923-4093-8BE5-C9E7B0701402

P356

Q47447521-2B6E2A7A-C5A0-4E2F-B4EB-D9491094B04C

P433

Q47447521-8C8605E5-B380-450F-A48E-854FE70AE4D8

P478

Q47447521-DFA09883-D3B0-4DF0-96FA-58719C6302D0

P577

Q47447521-FEAC2311-7213-4EB8-8E54-227548306868

P698

Q47447521-D19A81F4-90BF-4F6D-B638-FE8B3A959A2D

P932

Q47447521-0FF12C6E-E2A8-4171-BAAE-65AC8A354189

P356

2159-8290.CD-17-0996

P1433

Cancer Discovery

P1476

Targeting the Lysosome for Cancer Therapy.

@en

P2093

Andrew Thorburn

http://www.w3.org/2001/XMLSchema#string

Christina G Towers

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR inhibitors in cancer therapy

Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy

Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent.

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.

Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.

Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

Recent insights into the function of autophagy in cancer.

mTOR Signaling in Growth, Metabolism, and Disease.

A unified approach to targeting the lysosome's degradative and growth signaling roles.

P304

1218-1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-17-0996

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29097619

http://www.w3.org/2001/XMLSchema#string

P932

5966281

http://www.w3.org/2001/XMLSchema#string